S. Rutger Leliveld

994 total citations
16 papers, 705 citations indexed

About

S. Rutger Leliveld is a scholar working on Molecular Biology, Neurology and Infectious Diseases. According to data from OpenAlex, S. Rutger Leliveld has authored 16 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Neurology and 2 papers in Infectious Diseases. Recurrent topics in S. Rutger Leliveld's work include Prion Diseases and Protein Misfolding (7 papers), Neurological diseases and metabolism (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). S. Rutger Leliveld is often cited by papers focused on Prion Diseases and Protein Misfolding (7 papers), Neurological diseases and metabolism (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). S. Rutger Leliveld collaborates with scholars based in Germany, Netherlands and Spain. S. Rutger Leliveld's co-authors include Carsten Korth, Mathieu H. M. Noteborn, Jan Pieter Abrahams, Verian Bader, Jennifer Rohn, Ralf Klingenstein, Yinghui Zhang, Ingrid Prikulis, Gustavo Sajnani and Jesús R. Requena and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

S. Rutger Leliveld

16 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Rutger Leliveld Germany 13 502 173 131 71 65 16 705
José Alberto Carrodeguas Spain 18 675 1.3× 130 0.8× 73 0.6× 13 0.2× 58 0.9× 38 991
Anita Alexa Hungary 16 592 1.2× 67 0.4× 31 0.2× 14 0.2× 67 1.0× 28 773
Silvia Noiman Israel 14 486 1.0× 74 0.4× 50 0.4× 5 0.1× 197 3.0× 16 798
Yi Mo China 10 634 1.3× 57 0.3× 43 0.3× 20 0.3× 57 0.9× 27 788
Anna Caputo Italy 15 697 1.4× 29 0.2× 32 0.2× 237 3.3× 165 2.5× 30 1.2k
Asif Mir Pakistan 14 401 0.8× 217 1.3× 14 0.1× 48 0.7× 33 0.5× 42 732
Yuan Liao China 17 288 0.6× 67 0.4× 18 0.1× 179 2.5× 124 1.9× 41 849
Teresa M. Treweek Australia 15 771 1.5× 95 0.5× 33 0.3× 18 0.3× 37 0.6× 16 978
Yoko Mori Japan 18 460 0.9× 85 0.5× 5 0.0× 71 1.0× 42 0.6× 59 808
Shigeo Tomioka Japan 9 330 0.7× 60 0.3× 47 0.4× 12 0.2× 105 1.6× 12 526

Countries citing papers authored by S. Rutger Leliveld

Since Specialization
Citations

This map shows the geographic impact of S. Rutger Leliveld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Rutger Leliveld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Rutger Leliveld more than expected).

Fields of papers citing papers by S. Rutger Leliveld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Rutger Leliveld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Rutger Leliveld. The network helps show where S. Rutger Leliveld may publish in the future.

Co-authorship network of co-authors of S. Rutger Leliveld

This figure shows the co-authorship network connecting the top 25 collaborators of S. Rutger Leliveld. A scholar is included among the top collaborators of S. Rutger Leliveld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Rutger Leliveld. S. Rutger Leliveld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ottis, Philipp, Verian Bader, Svenja V. Trossbach, et al.. (2011). Convergence of Two Independent Mental Disease Genes on the Protein Level: Recruitment of Dysbindin to Cell-Invasive Disrupted-In-Schizophrenia 1 Aggresomes. Biological Psychiatry. 70(7). 604–610. 59 indexed citations
2.
Leliveld, S. Rutger, Gustavo Sajnani, Verian Bader, et al.. (2009). Oligomer Assembly of the C-Terminal DISC1 Domain (640−854) Is Controlled by Self-Association Motifs and Disease-Associated Polymorphism S704C. Biochemistry. 48(32). 7746–7755. 54 indexed citations
3.
Leliveld, S. Rutger, Verian Bader, Ingrid Prikulis, et al.. (2008). Insolubility of Disrupted-in-Schizophrenia 1 Disrupts Oligomer-Dependent Interactions with Nuclear Distribution Element 1 and Is Associated with Sporadic Mental Disease. Journal of Neuroscience. 28(15). 3839–3845. 103 indexed citations
4.
Müller‐Schiffmann, Andreas, Benjamin Petsch, S. Rutger Leliveld, et al.. (2008). Complementarity determining regions of an anti-prion protein scFv fragment orchestrate conformation specificity and antiprion activity. Molecular Immunology. 46(4). 532–540. 12 indexed citations
5.
Leliveld, S. Rutger, Lothar Stitz, & Carsten Korth. (2008). Expansion of the Octarepeat Domain Alters the Misfolding Pathway but Not the Folding Pathway of the Prion Protein. Biochemistry. 47(23). 6267–6278. 17 indexed citations
6.
Leliveld, S. Rutger & Carsten Korth. (2007). The use of conformation‐specific ligands and assays to dissect the molecular mechanisms of neurodegenerative diseases. Journal of Neuroscience Research. 85(11). 2285–2297. 17 indexed citations
7.
Klingenstein, Ralf, Stefan Löber, Pekka Kujala, et al.. (2006). Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent‐resistant membrane compartments. Journal of Neurochemistry. 98(3). 748–759. 74 indexed citations
8.
Klingenstein, Ralf, Stefan Löber, Pekka Kujala, et al.. (2006). Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent‐resistant membrane compartments. Journal of Neurochemistry. 98(5). 1696–1696. 4 indexed citations
9.
Klingenstein, Ralf, Patricia Melnyk, S. Rutger Leliveld, Adina Ryckebusch, & Carsten Korth. (2006). Similar Structure−Activity Relationships of Quinoline Derivatives for Antiprion and Antimalarial Effects. Journal of Medicinal Chemistry. 49(17). 5300–5308. 69 indexed citations
10.
Leliveld, S. Rutger, Remus T. Dame, Gijs J. L. Wuite, Lothar Stitz, & Carsten Korth. (2005). The Expanded Octarepeat Domain Selectively Binds Prions and Disrupts Homomeric Prion Protein Interactions. Journal of Biological Chemistry. 281(6). 3268–3275. 29 indexed citations
11.
Leliveld, S. Rutger. (2003). Apoptin protein multimers form distinct higher-order nucleoprotein complexes with DNA. Nucleic Acids Research. 31(16). 4805–4813. 34 indexed citations
12.
Oorschot, A. A. A. M. Danen-van, Yinghui Zhang, S. Rutger Leliveld, et al.. (2003). Importance of Nuclear Localization of Apoptin for Tumor-specific Induction of Apoptosis. Journal of Biological Chemistry. 278(30). 27729–27736. 122 indexed citations
13.
Leliveld, S. Rutger, Mathieu H. M. Noteborn, & Jan Pieter Abrahams. (2003). Prevalent conformations and subunit exchange in the biologically active apoptin protein multimer. European Journal of Biochemistry. 270(17). 3619–3627. 9 indexed citations
14.
Leliveld, S. Rutger, Remus T. Dame, Jennifer Rohn, Mathieu H. M. Noteborn, & Jan Pieter Abrahams. (2003). Apoptin's functional N‐ and C‐termini independently bind DNA. FEBS Letters. 557(1-3). 155–158. 24 indexed citations
15.
Leliveld, S. Rutger, Yinghui Zhang, Jennifer Rohn, Mathieu H. M. Noteborn, & Jan Pieter Abrahams. (2003). Apoptin Induces Tumor-specific Apoptosis as a Globular Multimer. Journal of Biological Chemistry. 278(11). 9042–9051. 58 indexed citations
16.
Valetti, Francesca, Sheila J. Sadeghi, Yergalem T. Meharenna, S. Rutger Leliveld, & Gianfranco Gilardi. (1998). Engineering multi-domain redox proteins containing flavodoxin as bio-transformer: preparatory studies by rational design. Biosensors and Bioelectronics. 13(6). 675–685. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026